Loading...

Loading...

 Biopharmaceuticals Respond to EG.5 Subvariant
By Anmol Motwani - Wed, 08/23/2023 - 16:17

Amidst surging COVID infections, key vaccine producers are rapidly refining their formulations to effectively tackle the emerging subvariant.